Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,654 | 80,205 | 86,131 | 112,447 | 152,489 |
| Marketable Securities | 233,172 | 193,617 | 252,221 | 278,344 | 246,685 |
| Receivables | 72,456 | 68,759 | 60,586 | 56,950 | 53,646 |
| Inventories | 7,562 | 4,450 | 29,781 | 28,683 | 29,630 |
| TOTAL | $427,125 | $363,457 | $447,100 | $495,966 | $502,466 |
| Non-Current Assets | |||||
| PPE Net | 7,421 | 7,663 | 7,831 | 7,910 | 8,999 |
| Investments And Advances | 19,426 | 64,317 | 0 | 0 | 0 |
| Intangibles | 0 | 24,525 | 0 | 0 | 0 |
| Other Non-Current Assets | 37,282 | 12,457 | 12,961 | 13,084 | 11,459 |
| TOTAL | $64,129 | $108,962 | $20,792 | $20,994 | $20,458 |
| Total Assets | $491,254 | $472,419 | $467,892 | $516,960 | $522,924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 33,000 | 28,974 | 26,022 | 23,565 | N/A |
| Accounts payable and accrued liabilities | 13,482 | 7,786 | 11,910 | 20,893 | 10,567 |
| Accrued Expenses | 104,197 | 89,598 | 79,249 | 102,882 | 77,392 |
| TOTAL | $153,567 | $129,065 | $119,921 | $149,988 | $90,763 |
| Non-Current Liabilities | |||||
| Long Term Debt | 796,108 | 808,481 | 813,036 | 811,265 | 833,181 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 522 |
| Other Non-Current Liabilities | 8,065 | 8,362 | 8,596 | 8,390 | 0 |
| TOTAL | $806,250 | $818,960 | $824,138 | $822,500 | $843,147 |
| Total Liabilities | $959,817 | $948,025 | $944,059 | $972,488 | $933,910 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 207,133 | 206,886 | 206,377 | 206,150 | 204,809 |
| Common Shares | 2,071 | 2,066 | 2,063 | 2,058 | 1,898 |
| Retained earnings | -1,743,245 | -1,729,212 | -1,716,538 | -1,681,159 | -1,619,428 |
| Other shareholders' equity | 2,293 | 557 | 771 | 1,337 | 800 |
| TOTAL | $-468,563 | $-475,606 | $-476,167 | $-455,528 | $-410,986 |
| Total Liabilities And Equity | $491,254 | $472,419 | $467,892 | $516,960 | $522,924 |